
    Original Text: Pathologically confirmed HER2-positive MBC by local laboratory with the following requirements: HER2 overexpressed or amplified (immunohistochemistry of 3+ or HER2 gene amplification by in situ hybridization with a ratio of HER2-gene signals to centromere 17 signals >= 2.0 or average HER2 copy number >= 6.0 signals/cells)
    Disease/Condition: Metastatic breast carcinoma
    Procedure: none
    Drug: none
    Biomarker: HER2+
    Computable Rule: Disease is "Metastatic breast carcinoma" AND HER2+ is True

Criterion:
    Patients must have measurable disease according to RECIST v1.1.

Output:
    Original Text: Patients must have measurable disease according to RECIST v1.1.
    Disease/Condition: Metastatic breast carcinoma
    Procedure: none
    Drug: none
    Biomarker: None
    Computable Rule